1
|
Pranata R, Soeroto AY, Huang I, Lim MA, Santoso P, Permana H, Lukito AA. Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19. Int J Tuberc Lung Dis 2020; 24:838-843. [PMID: 32912389 DOI: 10.5588/ijtld.20.0278] [Citation(s) in RCA: 61] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
OBJECTIVE: To investigate the association between chronic obstructive pulmonary disease (COPD) and smoking with outcome in patients with COVID-19.METHODS: A systematic literature search was performed using PubMed, EuropePMC, SCOPUS and the Cochrane Central Database. A composite of poor outcome, mortality, severe COVID-19, the need for treatment in an intensive care unit (ICU) and disease progression were the outcomes of interest.RESULTS: Data on 4603 patients were pooled from 21 studies. COPD was associated with an increased risk for composite poor outcome (OR 5.01, 95%CI 3.06-8.22; P < 0.001; I² 0%), mortality (OR 4.36, 95%CI 1.45-13.10; P = 0.009; I² 0%), severe COVID-19 (OR 4.62, 95%CI 2.49-8.56; P < 0.001; I² 0%), ICU care (OR 8.33, 95%CI 1.27-54.56; P = 0.03; I² 0%), and disease progression (OR 8.42, 95%CI 1.60-44.27; P = 0.01; I² 0%). Smoking was found to increase the risk of composite poor outcome (OR 1.52, 95%CI 1.16-2.00; P = 0.005; I² 12%), and subgroup analysis showed that smoking was significant for increased risk of severe COVID-19 (OR 1.65, 95%CI 1.17-2.34; P = 0.004; I² 11%). Current smokers were at higher risk of composite poor outcomes (OR 1.58, 95%CI 1.10-2.27; P = 0.01; I² 0%) than former/non-smokers.CONCLUSION: Our systematic review and meta-analysis revealed that COPD and smoking were associated with poor outcomes in patients with COVID-19.
Collapse
Affiliation(s)
- R Pranata
- Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia
| | - A Y Soeroto
- Division of Respirology and Critical Illness, Department of Internal Medicine
| | - I Huang
- Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia, Department of Internal Medicine, Faculty of Medicine
| | - M A Lim
- Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia
| | - P Santoso
- Division of Respirology and Critical Illness, Department of Internal Medicine
| | - H Permana
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia
| | - A A Lukito
- Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia, Department of Cardiology and Vascular Medicine, Siloam Hospitals Lippo Village, Tangerang, Indonesia
| |
Collapse
|
2
|
Dewi IMW, Soeroto AY, Putriyani G, Hanifah W, Permata A, Annisa J, Fithriyana I, Verweij PE, van Laarhoven A, de Veerdonk FLV, Alisjahbana B, van Crevel R. Aspergillus fumigatus-specific antibodies in patients with chronic tuberculosis. Int J Tuberc Lung Dis 2020; 24:853-856. [PMID: 32912393 DOI: 10.5588/ijtld.19.0802] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
- I M W Dewi
- Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands, Department of Biomedical Sciences, and, Infectious Diseases Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia, Radboud Centre of Infectious Diseases, Radboud University Medical Centre, Nijmegen, The Netherlands
| | - A Y Soeroto
- Respirology and Critical Illness Division, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia, Infectious Diseases Division, Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia
| | - G Putriyani
- Infectious Diseases Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
| | - W Hanifah
- Infectious Diseases Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
| | - A Permata
- Infectious Diseases Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
| | - J Annisa
- Infectious Diseases Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
| | - I Fithriyana
- Infectious Diseases Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
| | - P E Verweij
- Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands, ,
| | - A van Laarhoven
- Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands, Radboud Centre of Infectious Diseases, Radboud University Medical Centre, Nijmegen, The Netherlands
| | - F L van de Veerdonk
- Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands, Radboud Centre of Infectious Diseases, Radboud University Medical Centre, Nijmegen, The Netherlands
| | - B Alisjahbana
- Infectious Diseases Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia, Infectious Diseases Division, Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia
| | - R van Crevel
- Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands, Radboud Centre of Infectious Diseases, Radboud University Medical Centre, Nijmegen, The Netherlands
| |
Collapse
|